123 related articles for article (PubMed ID: 30056282)
1. Syntheses of C-ring modified dehydroabietylamides and their cytotoxic activity.
Wiemann J; Fischer L; Rohmer M; Csuk R
Eur J Med Chem; 2018 Aug; 156():861-870. PubMed ID: 30056282
[TBL] [Abstract][Full Text] [Related]
2. Ugi multicomponent-reaction: Syntheses of cytotoxic dehydroabietylamine derivatives.
Wiemann J; Fischer Née Heller L; Kessler J; Ströhl D; Csuk R
Bioorg Chem; 2018 Dec; 81():567-576. PubMed ID: 30248508
[TBL] [Abstract][Full Text] [Related]
3. Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
Xu H; Liu L; Fan X; Zhang G; Li Y; Jiang B
Bioorg Med Chem Lett; 2017 Feb; 27(3):505-510. PubMed ID: 28011223
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, cytotoxicities and DNA cleavage activities of dibenzoxepine and isoquinoline derivatives starting from dehydroabietylamine.
Liu CX; Lin ZX; Zhou AM
J Asian Nat Prod Res; 2016 Dec; 18(12):1169-1177. PubMed ID: 27696913
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumour activities of a novel class of dehydroabietylamine derivatives.
Chen Y; Lin ZX; Zhou AM
Nat Prod Res; 2012; 26(23):2188-95. PubMed ID: 22235912
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and structure-activity relationship of diterpenoids with a dehydroabietyl skeleton.
Rao X; Huang X; He L; Song J; Song Z; Shang S
Comb Chem High Throughput Screen; 2012 Dec; 15(10):840-4. PubMed ID: 22946842
[TBL] [Abstract][Full Text] [Related]
7. High anticancer potency on tumor cells of dehydroabietylamine Schiff-base derivatives and a copper(II) complex.
Zhao F; Wang W; Lu W; Xu L; Yang S; Cai XM; Zhou M; Lei M; Ma M; Xu HJ; Cao F
Eur J Med Chem; 2018 Feb; 146():451-459. PubMed ID: 29407970
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of podocarpane and totarane derivatives.
Mahdjour S; Guardia JJ; Rodríguez-Serrano F; Garrido JM; López-Barajas IB; Mut-Salud N; Chahboun R; Alvarez-Manzaneda E
Eur J Med Chem; 2018 Oct; 158():863-873. PubMed ID: 30248657
[TBL] [Abstract][Full Text] [Related]
9. (+)-Dehydroabietylamine derivatives target triple-negative breast cancer.
Ling T; Tran M; González MA; Gautam LN; Connelly M; Wood RK; Fatima I; Miranda-Carboni G; Rivas F
Eur J Med Chem; 2015 Sep; 102():9-13. PubMed ID: 26241873
[TBL] [Abstract][Full Text] [Related]
10. Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesterase.
Wiemann J; Loesche A; Csuk R
Bioorg Chem; 2017 Oct; 74():145-157. PubMed ID: 28797788
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel amides based on acridone scaffold with interesting antineoplastic activity.
Mahajan AA; Rane RA; Amritkar AA; Naphade SS; Miniyar PB; Bangalore PK; Karpoormath R
Anticancer Agents Med Chem; 2015; 15(5):555-64. PubMed ID: 25469511
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antileishmanial activity of C7- and C12-functionalized dehydroabietylamine derivatives.
Dea-Ayuela MA; Bilbao-Ramos P; Bolás-Fernández F; González-Cardenete MA
Eur J Med Chem; 2016 Oct; 121():445-450. PubMed ID: 27318121
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and bio-molecular study of (+)-N-Acetyl-α-amino acid dehydroabietylamine derivative for the selective therapy of hepatocellular carcinoma.
Mustufa MA; Ozen C; Hashmi IA; Aslam A; Baig JA; Yildiz G; Muhammad S; Solangi IB; Ul Hasan Naqvi N; Ozturk M; Ali FI
BMC Cancer; 2016 Nov; 16(1):883. PubMed ID: 27842576
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
Huang X; Huang R; Liao Z; Pan Y; Gou S; Wang H
Eur J Med Chem; 2016 Jan; 108():381-391. PubMed ID: 26706349
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and Chemotherapeutic Potential of Natural Rosin Abietane Diterpenoids and their Synthetic Derivatives.
Faustino C; Neto Í; Fonte P; Macedo A
Curr Pharm Des; 2018; 24(36):4362-4375. PubMed ID: 30648502
[TBL] [Abstract][Full Text] [Related]
16. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
17. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of antitumor activities and DNA cleavage on a class of dehydroabietylamine derivatives.
Liu CX; Lin ZX; Yu X; Lu Z; Zhou AM; Bao YL
Pharmazie; 2013 Nov; 68(11):861-5. PubMed ID: 24380233
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic Dehydroabietylamine Derived Compounds.
Wiemann J; Al-Harrasi A; Csuk R
Anticancer Agents Med Chem; 2020; 20(15):1756-1767. PubMed ID: 32183684
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and In Vitro Anticancer Activity of Novel Dehydroabietic Acid-Based Acylhydrazones.
Li FY; Wang X; Duan WG; Lin GS
Molecules; 2017 Jun; 22(7):. PubMed ID: 28661452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
